[Retracted] Analysis of the Clinical Effects of Sodium Valproate and Levetiracetam in the Treatment of Women with Epilepsy during Pregnancy

Table 2

Comparison of efficacy between the VPA group and LEV group (n (%)).

Group	n	Fully control	Markedly effective	Valid	Invalid	Total effective
VPA group	56	6 (10.71)	14 (25.00)	21 (37.50)	15 (26.79)	41 (73.21)
LEV group	68	11 (16.18)	29 (42.65)	22 (32.35)	6 (8.82)	62 (91.18)
t						5.343
						0.021